Venture
Humacyte, Inc.
Latest Form D 2018-06-26- CIK 1385943
- State NC
- Biotechnology
- 3 Form D offerings since 2009-11-23
- Total sold
- $275M
- across 3 offerings
- Rounds
- 3
- Form D offerings since 2009-11-23
- Latest round
- $150M
- 2018-06-26 · 021-315399
- Investors
- 1
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2018-06-26 · $150M
- 2009-11-23$49.8M021-109988
- 2018-03-09$75M021-307330
- 2018-06-26$150M021-315399
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($150M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-315399 | First filed2018-06-26 | Latest2018-06-26 | Sought$150M | Sold$150M | Investors1 | Exemptions506(b) |
| 021-307330 | First filed2018-03-09 | Latest2018-03-09 | Sought$75M | Sold$75M | Investors29 | Exemptions506(b) |
| 021-109988 | First filed2009-11-23 | Latest2015-01-20 | Sought$73.8M | Sold$49.8M | Investors6 | Exemptions506(b) |
Who backs Humacyte, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2018-06-26
| Name | Relationship |
|---|---|
| Robert Anderson | RelationshipDirector |
| Brady W. Dougan | RelationshipDirector |
| Robert S. Langer | RelationshipDirector |
| Laura E. Niklason | RelationshipDirector |
| Dale A. Sander | RelationshipDirector |
| Kathleen Sebelius | RelationshipDirector |
| Max N. Wallace | RelationshipDirector |
| Paul A. Boyer | RelationshipExecutive Officer |
| Carrie S. Cox | RelationshipExecutive Officer, Director |
| Theodore D. Lithgow | RelationshipExecutive Officer |
| Jeffrey H. Lawson | RelationshipExecutive Officer |
| William Tente | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- North Carolina (NC)
- Exemptions
- Rule 506(b)
- First filed
- 2009-11-23
- Latest filing
- 2018-06-26
Who backs Humacyte, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗